SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

RIZZI, Anna
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.898
AS - Asia 5.502
EU - Europa 3.302
SA - Sud America 748
AF - Africa 109
Continente sconosciuto - Info sul continente non disponibili 103
OC - Oceania 10
Totale 22.672
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.591
SG - Singapore 2.115
CN - Cina 1.427
DE - Germania 839
VN - Vietnam 615
BR - Brasile 575
UA - Ucraina 518
IT - Italia 436
GB - Regno Unito 400
HK - Hong Kong 375
FI - Finlandia 341
TR - Turchia 327
CA - Canada 192
FR - Francia 189
BD - Bangladesh 156
SE - Svezia 140
RU - Federazione Russa 138
IN - India 121
JP - Giappone 117
MX - Messico 69
PL - Polonia 69
AR - Argentina 47
ZA - Sudafrica 46
NL - Olanda 45
IQ - Iraq 40
BE - Belgio 39
ES - Italia 39
PK - Pakistan 31
LT - Lituania 29
ID - Indonesia 28
CO - Colombia 27
EC - Ecuador 26
VE - Venezuela 22
UZ - Uzbekistan 21
SA - Arabia Saudita 19
MA - Marocco 18
AE - Emirati Arabi Uniti 17
CZ - Repubblica Ceca 16
MY - Malesia 15
CL - Cile 13
JM - Giamaica 12
PH - Filippine 12
PY - Paraguay 12
TN - Tunisia 11
PE - Perù 10
AT - Austria 9
NP - Nepal 9
UY - Uruguay 9
AU - Australia 8
EG - Egitto 8
IL - Israele 8
CH - Svizzera 7
IR - Iran 7
JO - Giordania 7
DO - Repubblica Dominicana 6
IE - Irlanda 6
KE - Kenya 6
AL - Albania 5
BG - Bulgaria 5
BO - Bolivia 5
GR - Grecia 5
HN - Honduras 5
KR - Corea 5
RO - Romania 5
TT - Trinidad e Tobago 5
CR - Costa Rica 4
ET - Etiopia 4
HR - Croazia 4
KZ - Kazakistan 4
SN - Senegal 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AZ - Azerbaigian 3
BH - Bahrain 3
DZ - Algeria 3
LB - Libano 3
NO - Norvegia 3
PA - Panama 3
SV - El Salvador 3
TH - Thailandia 3
BB - Barbados 2
BJ - Benin 2
CY - Cipro 2
DK - Danimarca 2
GD - Grenada 2
KH - Cambogia 2
LK - Sri Lanka 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
RS - Serbia 2
SR - Suriname 2
AI - Anguilla 1
AM - Armenia 1
BF - Burkina Faso 1
BY - Bielorussia 1
BZ - Belize 1
CG - Congo 1
CV - Capo Verde 1
GA - Gabon 1
GE - Georgia 1
Totale 22.555
Salva come PNG Salva come JPEG
Città #
Ashburn 1.648
Singapore 1.408
Fairfield 1.156
Woodbridge 1.108
Houston 679
San Jose 675
Jacksonville 577
Ann Arbor 564
Chandler 513
Santa Clara 463
Seattle 455
Beijing 452
Wilmington 411
Cambridge 379
Hong Kong 370
Munich 340
Dallas 296
Los Angeles 278
New York 262
Ho Chi Minh City 204
Izmir 185
Helsinki 155
Nanjing 154
Hanoi 133
Milan 133
Princeton 114
Tokyo 113
Council Bluffs 108
San Diego 103
Boardman 100
Lauterbourg 97
Shanghai 91
Orem 80
Denver 77
São Paulo 73
Turku 72
Brooklyn 71
London 67
Atlanta 63
Montreal 62
Ferrara 61
Nanchang 61
Warsaw 58
Dearborn 55
Toronto 53
Chicago 49
Phoenix 47
Shenyang 47
Frankfurt am Main 46
Buffalo 45
San Francisco 44
Boston 38
Mexico City 38
Brussels 37
Hebei 35
Bremen 34
Falkenstein 33
Tianjin 33
Chennai 30
Da Nang 29
Hefei 29
Johannesburg 27
Manchester 26
Auburn Hills 25
Haiphong 25
Stockholm 25
Jiaxing 24
Mountain View 24
San Mateo 24
Rio de Janeiro 23
Falls Church 22
Mcallen 22
The Dalles 22
Norwalk 21
Philadelphia 21
Dhaka 20
Tashkent 20
Amsterdam 19
Changsha 19
Mumbai 19
Baghdad 18
Jinan 18
Moscow 18
Bologna 17
Montréal 17
Zhengzhou 17
Addison 16
Poplar 16
Secaucus 16
Redwood City 15
Calgary 14
Kunming 14
Lahore 14
Guangzhou 13
Jeddah 13
Rome 13
Tappahannock 13
Belo Horizonte 12
Hải Dương 12
Indiana 12
Totale 15.917
Salva come PNG Salva come JPEG
Nome #
Neurobiology, pharmacology, and medicinal chemistry of neuropeptide S and its receptor 1.250
[Nphe(1),Arg(14),Lys(15)]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor 398
Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8 ,9-tetrahydro-5H-benzocyclohepten-5-ol]: In vivo studies 323
A novel and facile synthesis of tetra branched derivatives of nociceptin/orphanin FQ 293
A new selective antagonist of the nociceptin receptor 280
Effects of vasoactive agents in healthy and diseased human saphenous veins 279
[Dmt(1) ]N/OFQ(1-13)-NH(2) , a potent nociceptin/orphanin FQ and opioid receptor universal agonist. 279
[(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor 274
Characterization of FR 172357, a new non-peptide bradykinin B2 receptor antagonist, in human, pig and rabbit preparations 272
Kinin B-1 and B-2 receptors in pig vessels: characterization of two monoreceptor systems 270
In vitro and in vivo studies on UFP-112, a novel potent and long lasting agonist selective for the nociceptin/orphanin FQ receptor 269
[(t)Bu-d-Gly(5)]NPS, a pure and potent antagonist of the neuropeptide S receptor: In vitro and in vivo studies 267
Human vascular kinin receptors of the B-2 type characterized by radioligand binding 263
Blockade of nociceptin/orphanin FQ receptor signaling in rat substantia nigra pars reticulata stimulates nigrostriatal dopaminergic transmission and motor behavior 260
A new ligand for the urotensin II receptor 259
Behavioural phenotypic characterization of CD-1 mice lacking the neuropeptide S receptor 259
Structure-activity studies on the nociceptin/orphanin FQ receptor antagonist 1-benzyl-N-{3-[spiroisobenzofuran-1(3H),4′-piperidin-1-yl]propyl} pyrrolidine-2-carboxamide 246
[Nphe(1)]nociceptin-(1-13)-NH2 antagonizes nociceptin effects in the mouse colon 242
Ala scan analogues of HOE 140. Synthesis and biological activities 241
Anxiolytic- and panicolytic-like effects of Neuropeptide S in the mouse elevated T-maze. 239
Nociceptin/orphanin FQ receptor knockout rats: In vitro and in vivo studies 237
Address and message sequences for the nociceptin receptor: A structure-activity study of nociceptin-(1-13)-peptide amide 236
Pharmacological studies on the NOP and opioid receptor agonist PWT2-[Dmt(1)]N/OFQ(1-13) 232
Peptide welding technology – A simple strategy for generating innovative ligands for G protein coupled receptors 232
Further studies on the pharmacological features of the nociceptin/orphanin FQ receptor ligand ZP120 230
Pharmacological characterization of the nociceptin receptor mediating hyperalgesia in the mouse tail withdrawal assay 229
UFP-112 a Potent and Long-Lasting Agonist Selective for the Nociceptin/Orphanin FQ Receptor 227
In vitro and in vivo pharmacological characterization of the novel NK(1) receptor selective antagonist Netupitant. 227
Pharmacological characterization of the nociceptin/orphanin FQ receptor non peptide antagonist Compound 24 222
Endogenous nociceptin/orphanin FQ signalling produces opposite spinal antinociceptive and supraspinal pronociceptive effects in the mouse formalin test: Pharmacological and genetic evidences 221
Further studies on nociceptin-related peptides: Discovery of a new chemical template with antagonist activity on the nociceptin receptor 220
Pharmacological characterisation of novel kinin B2 receptor ligands 220
In vitro and in vivo pharmacological characterization of nociceptin/orphanin FQ tetrabranched derivatives 220
Pharmacological characterization of tachykinin tetrabranched derivatives 220
Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl] methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol]: In vitro studies 217
Antinociceptive action of NOP and opioid receptor agonists in the mouse orofacial formalin test 217
B1 and B2 kinin receptors in various species 214
Effects of human urotensin II in isolated vessels of various species; comparison with other vasoactive agents 214
Synthesis and biological activity of human neuropeptide S analogues modified in position 2 213
Further studies at neuropeptide S position 5: Discovery of novel neuropeptide S receptor antagonists 212
UFP-101 antagonizes the spinal antinociceptive effects of nociceptin/orphanin FQ; Behavioral and electrophysiological studies in mice 209
In vitro and in vivo pharmacological characterization of Pronetupitant, a prodrug of the neurokinin 1 receptor antagonist Netupitant 209
In vitro functional characterization of novel nociceptin/orphanin FQ receptor agonists in recombinant and native preparations 208
[Arg(14), Lys(15)]nociceptin, a highly potent agonist of the nociceptin/orphanin FQ receptor: in vitro and in vivo studies 208
Pharmacological characterization of nociceptin receptor: an in vitro study 207
Structure-activity study of the nociceptin(1-13)-NH2 N-terminal tetrapeptide and discovery of a nociceptin receptor antagonist 206
Urotensin II stimulates plasma extravasation in mice via UT receptor activation 204
Altered anxiety-related behavior in nociceptin/orphanin FQ receptor gene knockout mice 203
Characterization of [Nphe(1)]nociceptin(1-13)NH2, a new selective nociceptin receptor antagonist 203
Synthesis and Biological Activity of Human Neuropeptide S Analogues Modified in Position 5: Identification of Potent and Pure Neuropeptide S Receptor Antagonists 202
Nociceptin receptor activation inhibits tachykinergic non adrenergic non cholinergic contraction of guinea pig isolated bronchus 201
In vitro and in vivo pharmacological characterization of the neuropeptide S receptor antagonist [D-Cys(tBu)5]neuropeptide S 199
Neuropeptide S is a stimulatory anxiolytic agent: A behavioural study in mice 198
Structure-activity study at positions 3 and 4 of human neuropeptide S. 196
In vitro characterization of J-113397, a non-peptide nociceptin/orphanin FQ receptor antagonist 196
Bradykinin receptors and receptor ligands (with special emphasis on vascular receptors) 194
Intrathecal administration of nociceptin/orphanin FQ receptor agonists in rats: A strategy to relieve chemotherapy-induced neuropathic hypersensitivity 191
Characterization of nociceptin receptors in the periphery: in vitro and in vivo studies 187
Anxiolytic-like effect of neuropeptide S in the rat defensive burying 186
Characterization of the human vascular kinin B2 receptor by binding assays. 185
In vitro and in vivo pharmacological characterization of the novel neuropeptide S receptor ligands QA1 and PI1 184
Pharmacological characterization of cebranopadol a novel analgesic acting as mixed nociceptin/orphanin FQ and opioid receptor agonist 183
Structure-activity relationships of nociceptin and related peptides: comparison with dynorphin A 181
Pharmacological characterisation of the first non-peptide bradykinin B2 receptor agonist FR 190997: An in vitro study on human, rabbit and pig vascular B2 receptors 181
Pharmacology of [Tyr(1)]nociceptin analogs: receptor binding and bioassay studies 179
Nociceptin/orphanin FQ receptor ligands 179
Structure-activity studies on neuropeptide S - Identification of the amino acid residues crucial for receptor activation 177
Structure-activity relationship study on human urotensin II 177
The nociceptin/orphanin FQ receptor antagonist, [Nphe(1)]NC(1-13)NH2, potentiates morphine analgesia 173
Pharmacological profile of hemokinin 1: a novel member of the tachykinin family 171
Pharmacology of nociceptin and its receptor: a novel therapeutic target 169
Studies on the antinociceptive effect of [Nphe(1)]nociceptin(1-13)NH2 in mice 167
Characterization of endothelin receptors in the human umbilical artery and vein 165
In vitro and in vivo pharmacological characterization of the nociceptin/orphanin FQ receptor ligand Ac-RYYRIK-ol 165
Spinal antinociceptive effects of the novel NOP receptor agonist PWT2-nociceptin/orphanin FQ in mice and monkeys 165
In vitro pharmacological profile of peptide III-BTD: A novel ligand for nociceptin/orphanin FQ and opioid receptors 162
Nociceptin receptor binding in mouse forebrain membranes: Thermodynamic characteristics and structure activity relationships 161
The mouse vas deferens: A pharmacological preparation sensitive to nociceptin 161
Pharmacological characterization of a vasopressin V1 receptor in the isolated human gastric artery 159
UFP-101, a peptide antagonist selective for the nociceptin/orphanin FQ receptor 159
Pharmacology of the Kallikrein-Kinin system 159
In vitro characterization of FR 190997, the first non peptide B2 receptor agonist receptor binding and bioassay in the human umbilical vein 158
Structure-activity studies of the Phe(4) residue of nociceptin(1-13)-NH2: Identification of highly potent agonists of the nociceptin/orphanin FQ receptor 156
Receptors for kinins in the human isolated umbilical vein 155
Endogenous nociceptin signaling and stress-induced analgesia 154
Receptor binding profile of novel nociceptin/orphanin FQ receptor ligands in mouse brain membranes 153
Effects of Ro 64-6198 it nociceptin/orphanin FQ-sensitive isolated tissues 153
Effects of naloxone benzoylhydrazone on native and recombinant nociceptin/orphanin FQ receptors 151
Further studies on nociceptin related peptides: discovery of new molecules with antagonist activity on the nociceptin receptor 147
In vitro and in vivo pharmacological characterization of a neuropeptide S tetrabranched derivative 147
FR 173657: a new, potent, nonpeptide kinin B2 receptor antagonist. An in vitro study 146
Involvement of the N/OFQ-NOP system in rat morphine antinociceptive tolerance: Are astrocytes the crossroad? 144
Contractile activity of endothelins and their precursors in human umbilical artery and vein: identification of distinct endothelin-converting enzyme activities 143
Receptor binding profile of novel nociceptin/orphanin FQ receptor ligands in mouse brain membranes. 143
Further studies on nociceptin/orphanin FQ related peptides: discovery of a new chemical template with antagonist activity on the OP4 receptor. 137
Pharmacological characterization of the nociceptin receptors in the mouse: receptor binding, bioassay and behavioral studies 134
Pharmacology of [tyr1]nociceptin analogs: receptor binding and bioassay studies 132
Characterization of the human vascular kinin B2 receptor by binding assays 131
MEN 11270, a novel selective constrained peptide antagonist with high affinity at the human B-2 kinin receptor 123
Pharmacological characterisation of [(pX)Phe4]nociceptin(1-13)NH2 analogues 2. In vivo studies 119
Totale 21.218
Salva come PNG Salva come JPEG
Categoria #
all - tutte 95.419
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 95.419
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.164 0 117 98 81 65 48 64 80 50 104 112 345
2022/20231.252 119 58 58 162 211 169 97 106 162 5 61 44
2023/2024646 73 82 30 16 35 131 24 57 9 12 21 156
2024/20252.838 67 70 209 108 326 315 126 171 418 239 430 359
2025/20267.583 849 329 619 1.013 1.132 476 892 377 707 719 320 150
2026/20271.502 1.285 217 0 0 0 0 0 0 0 0 0 0
Totale 22.672